Sandy Liebhard

Sandy A. Liebhard, a founding partner at Bernstein Liebhard LLP, has successfully represented plaintiffs in complex litigations for more than 20 years. As dedicated consumer advocates, Mr. Liebhard and his fellow attorneys have taken on some of the largest corporate interest in the nation in cases involving dangerous pharmaceuticals, faulty medical devices and defective consumer products. As an author for RXInuryHelp.com, Mr. Liebhard has written extensively on the litigation involving proton pump inhibitors (Nexium, Prilosec, PrevAcid, etc.) and kidney injuries; Risperdal and gynecomastia; the Bair Hugger forced air warming blanket; talcum powder and ovarian cancer; transvaginal mesh; power morcellators; defective hip implants; and more.

Mr. Liebhard is a 1988 graduate of Brooklyn Law School. He is admitted to the Bar of the State of New York, as well as the United States District Courts for the Southern and Eastern Districts of New York.


Aurobindo Hit with FDA Warning Letter After Valsartan Recalls

Aurobindo Pharmaceuticals, one of multiple generic drug makers to announce valsartan recalls over the past year, has received a Warning Letter from the U.S. Food & Drug Administration (FDA) for repeated violations at three plants in India. FDA Faults Aurobindo … Continue reading

FDA Petition Seeks Stronger Mental Health Warnings for Fluoroquinolone Antibiotics

The U.S. Food & Drug Administration (FDA) is being pushed once again to strengthen side effect warnings for fluoroquinolone antibiotics, a class of drugs that includes Levaquin, Cipro, and Avelox. Fluoroquinolone Antibiotics and Suicide In a petition filed with the … Continue reading

Johnson & Johnson Faces New Punitive Damages Trial After $12 Million Talcum Powder Verdict

A California woman who blames a life-time of talcum powder use for causing her mesothelioma has been given a second chance at punitive damages, after a judge in Alameda County Superior Court denied Johnson & Johnson’s bid to delay that … Continue reading

Blood Pressure Drug Recall: Cancer-Causing Chemical Detected in More Losartan Tablets

The U.S. Food & Drug Administration (FDA) has announced yet another blood pressure drug recall, after tests detected a potentially cancer-causing chemical in losartan tablets manufactured by Macleods Pharmaceuticals. The June 26th recall involves 22 drug lots sold to retail … Continue reading

Austrian Parliament First in Europe to Approve Total Glyphosate Ban

Austria has become the first European country to approve a total ban on glyphosate, the active ingredient in Monsanto Roundup. 3-Party Coalition Backed Glyphosate Ban The glyphosate ban passed the lower house of parliament on Tuesday, backed by an unusual … Continue reading

FDA Announces Class I IntraClude Device Recall Following Balloon Ruptures, Deaths

The U.S. Food & Drug Administration (FDA) has announced a Class I recall for Edwards Lifesciences Corp’s IntraClude Intra-Aortic Occlusion device. The IntraClude device recall follows nearly two-dozen reports of balloon ruptures, including three incidents in which patients died. What … Continue reading

FDA Approves Generic Febuxostat, Despite Recent Uloric Side Effects Warning

The U.S. Food & Drug Administration (FDA) has apparently approved a generic version of Uloric (febuxostat), Takeda Pharmaceutical’s controversial gout drug. India-based Alembic Pharmaceutical’s reported approval of its generic febuxostat on Tuesday, barely six months after deadly Uloric side effects … Continue reading

Medtronic Insulin Pump Recall Announced After Hacking Risk Discovery

Medtronic, Inc. is recalling thousands of MiniMed Insulin Pumps, warning that the device’s software could be vulnerable to hackers. “Security researchers have identified potential cybersecurity vulnerabilities related to these insulin pumps. An unauthorized person with special technical skills and equipment … Continue reading

Bayer Stock Soars on Monsanto Roundup Settlement Hope

Bayer AG stock was up sharply last week, amid speculation that the German company is moving closer to a settlement that would resolve thousands of Monsanto Roundup lawsuits pending in courts throughout the United States. Bayer Stock Fell 40% After … Continue reading

Ethicon Physiomesh Bellwether Trials Pushed Back Until April 2020

The federal court overseeing thousands of hernia mesh lawsuits involving Ethicon, Inc.’s Physiomesh Flexible Composite mesh has altered the proceeding’s bellwether trial schedule. Those trials were initially scheduled to begin in February 2020. But according to an amended Pretrial and … Continue reading

Follow Us

RXInjuryHelp.com on Google+  RXInjuryHelp.com on Facebook  RXInjuryHelp.com on LinkedIn  RXInjuryHelp.com on Twitter  RXInjuryHelp.com on YouTube  RXInjuryHelp.com on Pinterest

Skip to content